This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Owens, C. M. Articles by Dicks-Mireaux, C. Search for Related Content PubMed PubMed Citation Articles by Owens, C. M. Articles by Dicks-Mireaux, C.

Role of Chest Computed Tomography at Diagnosis in the Management of Wilms’ Tumor: A Study by the United Kingdom Children’s Cancer Study Group

From the Departments of Radiology and Haematology/Oncology, Great Ormond Street Hospital for Children National Health Service Trust, London; Department of Surgery, Institute of Child Health, London; and United Kingdom Children’s Cancer Study Group, Leicester, United Kingdom.

Address reprint requests to C.M. Owens, MD, Department of Diagnostic Radiology, Great Ormond Street Hospital for Children National Health Service Trust, London WC1N 3JH, United Kingdom.

PURPOSE: This study sought to determine whether the identification of minimal pulmonary metastatic disease by chest computed tomography (CT) performed at diagnosis in patients with Wilms’ tumor and normal chest x-rays (CXR) could predict a subgroup of children at increased risk of pulmonary relapse.

PATIENTS AND METHODS: A retrospective analysis was carried out of the records of 449 children entered onto the United Kingdom Childrens’ Cancer Study Group Second Wilms’ Tumor Study between July 1986 and September 1991. The imaging protocol did not stipulate chest CT at diagnosis, but 141 children who had normal frontal and lateral CXRs and a chest CT scan performed at diagnosis were eligible for analysis. After surgery, children with stage I Wilms’ tumor received single-agent chemotherapy (vincristine), whereas children with stages II, III, and bilateral Wilms’ tumor received combination chemotherapy. Most children with stage III tumors were also treated with abdominal radiotherapy (20 Gy).

RESULTS: In 31 patients (22%), pulmonary nodules were visible on chest CT; eight experienced relapse, four (15%) in the lungs. When only stage I patients were analyzed, there was a significant difference between the pulmonary relapse rate of 43% (three of seven) in the CT-positive group and 10% (five of 48) in the CT-negative group (P = .02). Four of eight patients with stage I disease with pulmonary relapse died.

CONCLUSION: CT seemed to identify a subgroup of stage I patients who were at increased risk of pulmonary relapse. These children had received only single-agent chemotherapy. A prospective randomized trial is needed to clarify whether these children would benefit from combination chemotherapy.

This article has been cited by other articles:

				M. B. McCarville, H. M. Lederman, V. M. Santana, N. C. Daw, S. J. Shochat, C.-S. Li, and R. A. Kaufman Distinguishing Benign from Malignant Pulmonary Nodules with Helical Chest CT in Children with Malignant Solid Tumors. Radiology, May 1, 2006; 239(2): 514 - 520. [Abstract] [Full Text] [PDF]

				K. Pritchard-Jones, A. Kelsey, G. Vujanic, J. Imeson, C. Hutton, and C. Mitchell Older Age Is an Adverse Prognostic Factor in Stage I, Favorable Histology Wilms' Tumor Treated With Vincristine Monochemotherapy: A Study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group J. Clin. Oncol., September 1, 2003; 21(17): 3269 - 3275. [Abstract] [Full Text] [PDF]

				D. M. Green Use of Chest Computed Tomography for Staging and Treatment of Wilms' Tumor in Children J. Clin. Oncol., June 15, 2002; 20(12): 2763 - 2764. [Full Text] [PDF]